 Novo Nordisk AS NVO Q3 2022 Investor Conference Call November 3, 2022 9:15 AM ET Company Participants Karsten Munk Knudsen Chief Financial Officer Camilla Sylvest Executive Vice President and Head-Commercial Strategy Corporate Affairs Ludovic Helfgott Executive Vice President and Head-Rare Disease Martin Holst Lange Executive Vice President, head-Development Conference Call Participants Keyur Parekh Goldman Sachs Naresh Chouhan Intron Mark Purcell Morgan Stanley Richard Vosser JPMorgan Jo Walton Credit Suisse Sachin Jain Bank of America Simon Baker Redburn Michael Leuchten UBS Wimal Kapadia Bernstein Emily Field Barclays Richard Parkes BNP Paribas Exane Keyur Parekh Good afternoon all, and thank you for joining us. My name is Keyur Parekh and I cover Novo for Goldman Sachs. 